PNEUMOCOCCAL INFECTIOUS DISEASE
Clinical trials for PNEUMOCOCCAL INFECTIOUS DISEASE explained in plain language.
Never miss a new study
Get alerted when new PNEUMOCOCCAL INFECTIOUS DISEASE trials appear
Sign up with your email to follow new studies for PNEUMOCOCCAL INFECTIOUS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New vaccine aims to shield kids from 24 pneumococcal strains
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new vaccine (PCV24) that protects against 24 types of pneumococcal bacteria, which can cause serious infections like pneumonia and meningitis. It involves 180 healthy children aged 2 to 23 months. The goal is to see if the vaccine is safe and triggers a strong …
Matched conditions: PNEUMOCOCCAL INFECTIOUS DISEASE
Phase: PHASE1 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 05:51 UTC
-
New vaccine aims to shield kids from 24 types of pneumonia
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new vaccine (RZ700) designed to protect infants and young children (ages 6 weeks to 71 months) against 24 types of pneumococcal bacteria, which can cause pneumonia and other serious infections. The trial will enroll 480 healthy children to check how well the va…
Matched conditions: PNEUMOCOCCAL INFECTIOUS DISEASE
Phase: PHASE2 • Sponsor: Shanghai Reinovax Biologics Co.,LTD • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 05:49 UTC
-
New vaccine trial aims to shield kids from deadly pneumonia
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new 13-valent pneumococcal vaccine (PCV13) in 3,080 healthy infants and children aged 6 weeks to 5 years. The goal is to see if the vaccine is safe and triggers a strong immune response against pneumococcal bacteria, which can cause pneumonia, meningitis, and e…
Matched conditions: PNEUMOCOCCAL INFECTIOUS DISEASE
Phase: PHASE3 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated May 22, 2026 13:53 UTC
-
New vaccine aims to shield kids from 24 pneumococcal strains
⭐️ VACCINE ⭐️ Recruiting nowThis study tests a new vaccine (PCV24) that protects against 24 types of pneumococcal bacteria, which can cause serious infections like pneumonia and meningitis. About 420 healthy children aged 2 months to 5 years will receive either the new vaccine or an existing one to compare …
Matched conditions: PNEUMOCOCCAL INFECTIOUS DISEASE
Phase: PHASE2 • Sponsor: Sinovac Life Sciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated May 14, 2026 12:06 UTC